APOA2 and COVID-19: For example, Apolipoprotein A-II (APOA2), a key component of high-density lipoprotein (HDL), has been reported to be dysregulated in patients with COVID-19, reflecting alterations in lipid metabolism and the host inflammatory response51–53.